Alan Y. L. Jiang

Alan Y. L. Jiang

Auto-generated profile, based on publicly available information

Alan Y. L. Jiang

Department of Biomedical Engineering University of California Irvine Irvine California USA

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2019 in Biomicrofluidics
Verified
Journal Article
Open access
PDF file
AJAlan Y. L. Jiang
Alan Y. L. Jiang
AYAndrew R. Yale
Andrew R. Yale
MAMohammad Aghaamoo
Mohammad Aghaamoo
DLDo-Hyun Lee
Do-Hyun Lee
ALAbraham Lee
Abraham Lee
LFLisa A. Flanagan
Lisa A. Flanagan
We created an integrated microfluidic cell separation system that incorporates hydrophoresis and dielectrophoresis modules to facilitate high-throughput continuous cell separation. The hydrophoresis module consists of a serpentine channel with ridges and trenches to generate a diverging fluid flow that focuses cells into two streams along the channel edges. The dielectrophoresis module is composed of a chevron-shaped electrode array. Separation in the dielectrophoresis module is driven by inherent cell electrophysiological properties and does not require cell-type-specific labels. The chevron shape of the electrode array couples with fluid flow in the channel to enable continuous sorting of cells to increase throughput. We tested the new system with mouse neural stem cells since their electrophysiological properties reflect their differentiation capacity (e.g., whether they will differentiate into astrocytes or neurons). The goal of our experiments was to enrich astrocyte-biased cells. Sorting parameters were optimized for each batch of neural stem cells to ensure effective and consistent separations. The continuous sorting design of the device significantly improved sorting throughput and reproducibility. Sorting yielded two cell fractions, and we found that astrocyte-biased cells were enriched in one fraction and depleted from the other. This is an advantage of the new continuous sorting device over traditional dielectrophoresis-based sorting platforms that target a subset of cells for enrichment but do not provide a corresponding depleted population. The new microfluidic dielectrophoresis cell separation system improves label-free cell sorting by increasing throughput and delivering enriched and depleted cell subpopulations in a single sort.

22 September 2025 in Bioengineering & Translational Medicine
Verified
Journal Article
Open access
AJAlan Y. L. Jiang
Alan Y. L. Jiang
AYAndrew R. Yale
Andrew R. Yale
JHJ. Nicole Hanamoto
J. Nicole Hanamoto
NLNicole S. Lav
Nicole S. Lav
VDVi Phuong Dang
Vi Phuong Dang
LFLisa A. Flanagan
Lisa A. Flanagan
Diffuse gliomas are brain tumors that include oligodendroglioma, astrocytoma, and glioblastoma (GBM), the most common and deadly primary brain tumor. A major challenge in glioma treatment is resistance to the first‐line chemotherapeutic, temozolomide (TMZ). Plasma membrane properties of cells with increased chemotherapeutic resistance are not well understood, despite the fact that the membrane is the first point of contact with the environment and greatly shapes cell behavior. Plasma membrane glycosylation impacts cell function, and we found significant differences in glycosylation of TMZ‐resistant cells. We further identified plasma membrane electrophysiological properties predicting glioma cell TMZ resistance. We enriched cells with higher TMZ resistance by sorting glioma cells based on electrophysiological properties, indicating the relevance of membrane properties to chemotherapeutic resistance. These findings could lead to rapid separation methods for patient tumor cells, a better understanding of the molecular profiles of resistant cells, and novel treatment options for gliomas.